Medication does not slow progression of coronary disease in patients with prehypertension

Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme secreted by the kidneys) inhibitor aliskiren, compared with placebo, did not result in improvement or slowing in the progression of coronary atherosclerosis, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology Congress 2013...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Heart Disease Source Type: news